【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Peripheral Artery Occlusive Disease (PAOD) Overview 11
Therapeutics Development 12
Pipeline Products for Peripheral Artery Occlusive Disease (PAOD) – Overview 12
Pipeline Products for Peripheral Artery Occlusive Disease (PAOD) – Comparative Analysis 13
Peripheral Artery Occlusive Disease (PAOD) – Therapeutics under Development by Companies 14
Peripheral Artery Occlusive Disease (PAOD) – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Peripheral Artery Occlusive Disease (PAOD) – Products under Development by Companies 22
Peripheral Artery Occlusive Disease (PAOD) – Companies Involved in Therapeutics Development 26
Annexin Pharmaceuticals AB 26
Apceth GmbH & Co. KG 27
AstraZeneca PLC 28
Athersys, Inc. 29
Bayer AG 30
Betagenon AB 31
Cardiolynx AG 32
CardioVascular BioTherapeutics, Inc. 33
Celgene Corporation 34
Cytokinetics, Inc. 35
Diffusion Pharmaceuticals LLC 36
DNAVEC Corporation 37
Genovate Biotechnology Co., LTD. 38
Grifols, S.A. 39
Human Stem Cells Institute 40
Kowa Company, Ltd. 41
Lacer, S.A. 42
Ligand Pharmaceuticals, Inc. 43
LTT Bio-Pharma Co., Ltd. 44
miRagen Therapeutics, Inc. 45
Multi Gene Vascular Systems Ltd 46
Nuo Therapeutics, Inc. 47
Pluristem Therapeutics Inc. 48
Proteon Therapeutics, Inc. 49
Recardio GmbH 50
RegenoCELL Therapeutics, Inc. 51
Rigel Pharmaceuticals, Inc. 52
Sagene Pharmaceuticals, Inc. 53
Stemedica Cell Technologies, Inc. 54
Taisho Toyama Pharmaceutical Co., Ltd. 55
Theravasc, Inc. 56
vasopharm GmbH 57
ViroMed Co., Ltd. 58
Peripheral Artery Occlusive Disease (PAOD) – Therapeutics Assessment 59
Assessment by Monotherapy Products 59
Assessment by Combination Products 60
Assessment by Target 61
Assessment by Mechanism of Action 63
Assessment by Route of Administration 65
Assessment by Molecule Type 67
Drug Profiles 69
(cilostazol + organic nitrate) ER – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
AEM-28 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
ALD-301 – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
Alecmestencel-T – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
alprostadil – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
Annexin A-5 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
AP-01 – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
cilostazol CR – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
clopidogrel bisulfate – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
CVBT-141C – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
DVC1-0101 – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
ELS-140 – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
Gene Therapy for Critical Limb Ischemia and Peripheral Arterial Disease – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
Gene Therapy to Activate Vascular Endothelial Growth Factor for Cardiovascular Disease and Central Nervous System Disorders – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Human Plasmin – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
K-134 – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
LA-419 – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
LT-0101 – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Mesenchymal Stem Cells – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
MGN-6114 – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
MultiGeneAngio – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
MultiGeneGraft – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
MultiStem – Drug Profile 95
Product Description 95
Mechanism of Action 95
R&D Progress 95
O-304 – Drug Profile 98
Product Description 98
Mechanism of Action 98
R&D Progress 98
PDA-002 – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
R-118 – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
REC-03 – Drug Profile 101
Product Description 101
Mechanism of Action 101
R&D Progress 101
rivaroxaban – Drug Profile 102
Product Description 102
Mechanism of Action 102
R&D Progress 102
selegiline + Antiplatelet Drugs – Drug Profile 107
Product Description 107
Mechanism of Action 107
R&D Progress 107
sodium nitrite – Drug Profile 108
Product Description 108
Mechanism of Action 108
R&D Progress 108
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 110
Product Description 110
Mechanism of Action 110
R&D Progress 110
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 112
Product Description 112
Mechanism of Action 112
R&D Progress 112
SYN-20112312RU – Drug Profile 113
Product Description 113
Mechanism of Action 113
R&D Progress 113
ticagrelor – Drug Profile 114
Product Description 114
Mechanism of Action 114
R&D Progress 114
tirasemtiv – Drug Profile 117
Product Description 117
Mechanism of Action 117
R&D Progress 117
transcrocetinate sodium – Drug Profile 123
Product Description 123
Mechanism of Action 123
R&D Progress 123
TXA-127 – Drug Profile 124
Product Description 124
Mechanism of Action 124
R&D Progress 124
VAS-2870 – Drug Profile 126
Product Description 126
Mechanism of Action 126
R&D Progress 126
VM-202 – Drug Profile 127
Product Description 127
Mechanism of Action 127
R&D Progress 127
vonapanitase – Drug Profile 129
Product Description 129
Mechanism of Action 129
R&D Progress 129
Peripheral Artery Occlusive Disease (PAOD) – Recent Pipeline Updates 130
Peripheral Artery Occlusive Disease (PAOD) – Dormant Projects 166
Peripheral Artery Occlusive Disease (PAOD) – Discontinued Products 171
Peripheral Artery Occlusive Disease (PAOD) – Product Development Milestones 173
Featured News & Press Releases 173
Feb 02, 2015: The Small molecule AMPK activator O304 acts as an oral PCSK9 inhibitor 173
Jan 08, 2015: Journal of Cardiovascular Pharmacology Publishes Positive Nonclinical Results of Proteon Therapeutics’ PRT-201 in Peripheral Artery Disease 173
Sep 29, 2014: Annexin Pharmaceuticals Announces Patent 174
Sep 02, 2014: Capstone Therapeutics Announces Phase 1a Results for AEM-28 Showing Safety and Biomarker Efficacy Signals 174
Jul 09, 2014: Development Of Russian Innovative Drug For Peripheral Arterial Disease Is Supported By The Council Of Maryland Biotech Companies (USA) 175
Mar 17, 2014: AstraZeneca Announces Progress on Global PARTHENON Clinical Trial Program with BRILINTA in High-Risk Cardiovascular Disease Patient Populations in Advance of American College of Cardiology Scientific Session 176
Mar 06, 2014: Rigel Announces Publication of R118 AMPK Activator Research 178
Nov 13, 2013: Pluristem Receives Regulatory Approval to Extend Its Phase II Study of PLX-PAD Cells in the Treatment of Intermittent Claudication to South Korea 179
Oct 02, 2013: Pluristem Receives Israeli Ministry of Health Approval to Expand Its Phase II Clinical Trial in Intermittent Claudication to Israel 180
Sep 16, 2013: FDA Lifts Clinical Hold of Pluristem’s Phase II Intermittent Claudication Study 180
Appendix 181
Methodology 181
Coverage 181
Secondary Research 181
Primary Research 181
Expert Panel Validation 181
Contact Us 181
Disclaimer 182
【レポート販売概要】
■ タイトル：末梢動脈閉塞性疾患(Peripheral Artery Occlusive Disease (PAOD))：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015
■ 発行日：2015年3月11日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6257IDB
■ 調査対象地域：グローバル
- 乳房生検の世界市場2017-2021About Breast BiopsyA breast biopsy is a procedure that involves the removal of tissue or fluid from the targeted area. The tissue is examined under a microscope and then tested to determine the presence of breast cancer. A biopsy is the only diagnostic procedure to confirm cancer. About 80% of women who undergo breast biopsy do not have breast cancer. Technavio’s analysts forecast the global breas …
- 人工心臓弁（医療機器）のグローバル新興国市場（2012-2018）The Cardiac Prosthetic Heart Valves market value is expected to reach US$468 million by 2016, primarily supported by the product types - Mechanical Heart Valves, Transluminal Heart Valves and Tissue Heart Valves. China accounts for nearly 26% of the market share and India claims more than 20% of the total share. In terms of CAGR, India is the fastest growing region while China and South Korea are …
- 世界の紙ストロー市場：材料種類別（バージンペーパー、再生紙）、製品種類別（印刷、非印刷）、ストロー長さ別、ストロー直径別、エンドユーズ用途別（食品サービス、施設、家庭）、地域別Increased demand for paper straws for various end-use applications and rise in government reforms & campaigns to ban plastics are projected to drive the overall growth of the paper straw market across the globe from 2019 to 2024. The paper straw market is projected to grow from USD 585 million in 2019 to USD 1,687 million by 2024, recording a CAGR of 23.6% during the forecast period. The growing c …
- 炭酸飲料加工装置の世界市場予測（～2022年）：砂糖溶解機、炭酸化機械、ミキサー、熱交換器“Carbonated beverage processing equipment market is projected to grow at a CAGR of 5.8%”The carbonated beverage processing equipment market is projected to reach USD 7.23 billion by 2022, at a CAGR of 5.8% from 2017 to 2022. The market is driven by factors such as carbonated soft drink manufacturers’ requirement for advanced equipment with multifunctional features and optimum output, and increased …
- 自動車用可変容量ターボチャージャー（VGT）の世界市場About Automotive VGT An automotive turbocharger is a component that helps the engine to produce additional power and improves the overall performance of the vehicle. The turbocharger has two components: turbine and compressor. It uses the exhaust air that is released after fuel and air combustion in a vehicle combustion chamber. When this exhaust air strikes the turbine blades, it causes the turbi …
- 水中ポンプの世界市場動向及び予測Global submersible pumps market was valued at USD 8.8 billion in 2014 and is projected to reach USD 12.2 billion by 2020, at a CAGR of 5.4% during the forecast period 2015 to 2020. The report offers detailed analysis of submersible pumps market, with regards to the current scenario and the trends prevailing in the industry. Key segments of submersible pumps market across various regions and countr …
- ヒトパピローマウイルス（HPV）検査機器の世界市場About HPV HPV refers to a group of more than 200 related viruses commonly causing infections that do not have any symptoms. Among these, more than 40 types of HPV cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections ar …
- SCRパワーコントローラーの世界市場予測（～2023年）The SCR power controller market is estimated to be worth USD 130.6 Million in 2017 and is expected to reach USD 171.3 Million by 2023, at a CAGR of 4.62% between 2017 and 2023. The growth of this market is propelled by the rising demand for digitization of SCR power controllers across various applications. The market for three-phase SCR power controllers is expected to grow at a higher CAGR than t …
- 世界のセラミックコーティング市場：Global Ceramic Coating Market 2014-2018TechNavio's analysts forecast the Global Ceramic Coating market to grow at a CAGR of 7.24 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in ceramic coating of automotive components. The Global Ceramic Coating market has also been witnessing the increasing use of plasma-sprayed ceramic coating. However, the high total cost of ownership c …
- 移動式ミニ冷蔵庫の世界市場2016-2020About Portable Mini Fridge A portable mini fridge is the best option to keep food, beverage, medicines, and cosmetics cool while travelling. These mini fridges are smaller and lighter than conventional refrigerators. So, consumers can set them up wherever they want immediately after purchase. A light weight is a key property of these fridges. Due to this property, travelers install them in their v …
- ビタミンDの世界市場：ビタミンD2、ビタミンD3Vitamins, essential micronutrients, also known as vital amines, are essential in micro quantities to ensure normal metabolism and growth of the body. Vitamin D is a fat-soluble vitamin, which is essential for proper absorption of calcium and phosphorus in the intestinal tract of a body. It also helps in normal growth and development of bone and teeth, prevents muscle weakness, and regulates blood …
- イースト（酵母）の世界市場：パン用イースト、醸造イースト、ワイン用イースト、バイオエタノールイースト、飼料用イーストThe global market for yeast & specialty yeast has been growing steadily during the last few decades. In terms of value, the market is projected to reach USD 4.95 Billion by 2021, at a CAGR of 8.9% from 2016 to 2021 and is projected to reach 3,115.2 KT in terms of volume by 2021, at a CAGR of 6.9%. Rising demand for bakery products and demand for bio-ethanol as fuel are driving the market for yeast …
- 世界のトランスペアレントキャッシング（透過型キャッシュ）市場（2014-2018）About Transparent Caching Caching is the temporary storage of web content which helps in offloading the origin web or application server. Transparent caching is a solution that enables the service provider to offload a significant amount of content traffic by storing a cached copy of the popular content close to the edge of the network, which is delivered to the user directly from the edge of the …
- 世界の遺伝性疾患、癌、法医学的・親子鑑定分子診断検査市場Complete report $8,750. DataPack (test volumes, sales forecasts, supplier shares) $5,400. The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. This new seven-country study from Venture Planning Group contains 570 pages, 42 tables, and is designed to help current suppliers and potential market e …
- Ependymoma：グローバル臨床試験レビューH2, 2013Ependymoma Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Ependymoma Global Clinical Trials Review, H2, 2013" provides data on the Ependymoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ependymoma. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
